Search company, investor...

Novation Pharmaceuticals

Stage

Other Investors | Alive

About Novation Pharmaceuticals

Novation is focusing on the development of small molecular weight drugs that affect the stability of messenger RNA. Initial development efforts are on the treatment and prevention of cancer and chronic inflammatory diseases.

Headquarters Location

United Kingdom

Missing: Novation Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Novation Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Novation Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Novation Pharmaceuticals is included in 1 Expert Collection, including Cancer.

C

Cancer

4,784 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

Novation Pharmaceuticals Patents

Novation Pharmaceuticals has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/1/2004

10/6/2009

Transcription factors, Molecular biology, Gene expression, Biotechnology, RNA

Grant

Application Date

4/1/2004

Grant Date

10/6/2009

Title

Related Topics

Transcription factors, Molecular biology, Gene expression, Biotechnology, RNA

Status

Grant

Novation Pharmaceuticals Frequently Asked Questions (FAQ)

  • What is Novation Pharmaceuticals's latest funding round?

    Novation Pharmaceuticals's latest funding round is Other Investors.

  • Who are the investors of Novation Pharmaceuticals?

    Investors of Novation Pharmaceuticals include Novartis Venture Funds.

  • Who are Novation Pharmaceuticals's competitors?

    Competitors of Novation Pharmaceuticals include Reata Pharmaceuticals, Bellicum Pharmaceuticals, Curetis, TxCell, Alfama and 15 more.

Compare Novation Pharmaceuticals to Competitors

Can-Fite BioPharma Logo
Can-Fite BioPharma

Can-Fite BioPharma is a biopharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities.

A
AiRNA Pharmaceuticals

AiRNA's focus is to develop RNAi drugs for cancer, inflammation, and infectious diseases.

O
Oxagen

Oxagen is a biopharmaceutical company that develops small molecule drugs for inflammatory and respiratory diseases.

B
Biolipox Ab

Orexo is a pharmaceutical company, focusing on development of new, patented drugs by combining well-documented substances with innovative technologies, and the development of new treatments for respiratory and inflammatory diseases.

M
MIGENIX

MIGENIX is committed to advancing therapy, improving health, and enriching life by developing and commercializing drugs for the treatment of infectious diseases. The Company's programs include drug candidates for: the prevention of catheter-related infections (Phase III), the treatment of dermatological diseases (end of Phase II), the treatment of chronic hepatitis C infections (Phase II and preclinical), the treatment of serious gram positive bacterial infections (preclinical) and the treatment of hepatitis B infections (preclinical). MIGENIX is headquartered in Vancouver, British Columbia, Canada.

M
Mimetogen Pharmaceuticals

Mimetogen is actively pursuing the development of novel small molecule compounds to treat neurodegenerative diseases of the eye, including dry eye, glaucoma and retinitis pigmentosa. The company designs and develops small molecule drugs that mimic the effects of neurotrophins, proteins that help maintain the health and growth of many cells and tissues found in the eye. Making drugs that can mimic the large natural molecules may lead to the development of novel approaches to treat degenerative ocular diseases such as glaucoma, retinitis pigmentosa, age-related macular degeneration and dry eye.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.